Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Заявленная компания
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions читать еще
My overall experience at Karyopharm has been good. As an organization, we've come far and it is my belief we will go even further with our new leadership team. We will continue working hard to make a difference in the lives of patients and their families.
Что вам больше всего нравится в команде руководства?
The open-door policy and inclusiveness
Чем вы больше всего довольны в вашем пакете компенсаций?
The level of coverage received
Что самое позитивное вы можете сказать о культуре и обстановке на вашей работе?
We have a healthy and open communication culture at Karyopharm.
Что приносит вам больше всего счастья/радости на работе?
I'm most happy working with others I can learn from who exhibit their appreciation for my contributions regularly.
Каковы самые лучшие качества в вашей команде?
We work tremendously well in a collaborative and supportive manner. We successfully meet identified goals and have a good time during the process.
Other Employee Reviews for Karyopharm Therapeutics
×